175 Czech MDS Group experience with azacitidine in treatment of high risk MDS and AML patients
Titel:
175 Czech MDS Group experience with azacitidine in treatment of high risk MDS and AML patients
Auteur:
Jonasova, A. Cermak, J. Cervinek, L. Novakova, L. Vondrakova, J. Belohlavkova, P. Sykora, M. Seifertova, N. Walterova, L. Libiger, J. Michalova, K. Zemanova, Z. Brezinova, J. Kacmarova, K. Klapka, R.